Japan's Rule-Relaxation Leads Drug, Device Makers To Expand Operations
This article was originally published in PharmAsia News
Executive Summary
Japan's move to ease its drug-regulation process is leading foreign makers of drugs and medical devices to beef up their operations in the country to get an edge in the world's second-largest market in both sectors.